Sanofi India Ltd. (SANOFI) 52 Week Low Streak: Sixth Straight Session Near Yearly Low
- September 29, 2026
- Posted by: Chaitanya Auti
- Category: News
Sanofi India Ltd. has now traded within 2% of its 52-week low for its sixth consecutive session, with the stock moving down 0.88% across the streak. At 9:53 AM IST on 19 October 2026, it was last traded at Rs 2,919.65 after touching an intraday low of Rs 2,916.75. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued weakness.
The stock previously stood at Rs 2,941.8, opened at Rs 2,934 and touched a high of Rs 2,934 in the current session, while the market capitalisation stood at Rs 6,775.15 crore. For readers, this is less about one session’s move and more about a sustained pattern of trading close to the one-year trough, which keeps the Sanofi India Ltd. 52 Week Low Streak in focus for market watchers and long-term investors.
Sanofi India Ltd. 52 Week Low Streak: Consecutive Low Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,919.65 |
| Previous Close | Rs 2,941.8 |
| Today's Move | Rs -22.15 (-0.75%) |
| Open | Rs 2,934 |
| High | Rs 2,934 |
| Low | Rs 2,916.75 |
| Market Capitalisation | Rs 6,775.15 crore |
Sanofi India Ltd. (SANOFI) traded at Rs 2,919.65 versus the previous close of Rs 2,941.8, a fall of 0.75%. The stock opened at Rs 2,934, reached a high of Rs 2,934, touched a low of Rs 2,916.75.
Sanofi India Ltd. Share Price Today reflects another weak session, with the stock trading below its previous close of Rs 2,941.8 and last traded at Rs 2,919.65, down Rs 22.15 or 0.75%. The day opened at Rs 2,934 and also touched the same level as its high, which means the stock has stayed near the lower end of its day range from the start. The intraday low of Rs 2,916.75 shows that the stock is still hovering close to its one-year low zone.
The market capitalisation of Rs 6,775.15 crore places Sanofi India Ltd. among the more valuable names in its industry, even though the share price remains under pressure. The repeated proximity to the yearly low makes this a Sanofi India Ltd. Share Price story about persistence of weakness rather than a single-day gap-down move. In practical terms, the current trade setup shows that the Sanofi India Ltd. 52 Week Low Streak is not just a one-off event, but a multi-session pattern that investors may want to track alongside fundamentals and sector valuation.
What the Repeated 52-Week Lows Show
The Sanofi India Ltd. 52 Week Low Streak now stretches across six straight sessions, which means the stock has remained within a narrow band of its 52-week floor for nearly a week of trading. The cumulative decline of 0.88% across the streak is modest in percentage terms, but the key point is consistency: the stock has repeatedly stayed close to its yearly low instead of moving away from it. That pattern matters more than a single day’s slip because it shows ongoing price weakness over time.
What the latest data does not show is why the stock has remained pinned near that range. The repeated-low pattern is visible, but no company-specific trigger is confirmed here. For a Sanofi India Ltd. 52 Week Low Streak article, that distinction is important: the market has clearly kept the stock near its one-year trough, yet the reason must be sought in broader financial and sector context rather than assumed from the price action alone.
Sanofi India Ltd. (SANOFI) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 6,775.15 crore |
| P/E Ratio | 20.92x |
| P/B Ratio | 8.2x |
| ROE | 44.5% |
| ROCE | 55.46% |
| EPS | Rs 140.6 |
| Book Value Per Share | Rs 358.67 |
| Dividend Yield | 4.18% |
Sanofi India Ltd. (SANOFI) fundamental metrics show P/E 20.92x, P/B 8.2x, ROE 44.5%, ROCE 55.46%. These figures provide context only and are not a buy or sell signal.
Sanofi India Ltd. has a market capitalisation of Rs 6,775.15 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 20.92x, P/B at 8.2x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 44.5% and ROCE of 55.46%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 140.6, book value per share of Rs 358.67, dividend yield of 4.18%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.76x, median ROE of 10.88%, median ROCE of 12.96%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 20.92x |
| Benchmark Median P/E | 26.76x |
| Benchmark Average P/E | 39.11x |
| Benchmark P/E Range | 0x to 629.67x |
| Company P/B Ratio | 8.2x |
| Benchmark Median P/B | 2.78x |
| Company ROE | 44.5% |
| Benchmark Median ROE | 10.88% |
| Company ROCE | 55.46% |
| Benchmark Median ROCE | 12.96% |
| Company Market Capitalisation | Rs 6,775.15 crore |
| Benchmark Median Market Cap | Rs 709.41 crore |
Sanofi India Ltd. (SANOFI) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Sanofi India Ltd. (SANOFI) has a P/E ratio of 20.92x, which is below the benchmark median of 26.76x, a difference of -21.82%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sanofi India Ltd. (SANOFI) has a ROE of 44.5%, which is above the benchmark median of 10.88%, a difference of +309.01%. Sanofi India Ltd. (SANOFI) has a ROCE of 55.46%, which is above the benchmark median of 12.96%, a difference of +327.93%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Morepen Laboratories Ltd. | MOREPENLAB | 6,772.71 | 48.19 | 5.2 | 7.96 | 10.19 |
| Bliss GVS Pharma Ltd. | BLISSGVS | 7,008.58 | 51.46 | 5.68 | 12.11 | 17.4 |
| Supriya Lifescience Ltd. | SUPRIYA | 7,129.17 | 35.94 | 5.84 | 19.06 | 25.3 |
| SENORES PHARMACEUTICALS L | SENORES | 6,057.66 | 47.94 | 6.29 | 14.14 | 15.66 |
| Innova Captab Ltd. | INNOVACAP | 5,840.38 | 37.37 | 5.15 | 13.75 | 15.04 |
Sanofi India Ltd. (SANOFI) has a P/E ratio of 20.92x compared with the displayed peer median of 47.94x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 44.5% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 55.46% versus the displayed peer median of 15.66%, providing a capital-efficiency comparison. Sanofi India Ltd. (SANOFI) has a market capitalisation of Rs 6,775.15 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching
- Sanofi India Ltd. has traded near its 52-week low for six straight sessions, which keeps the Sanofi India Ltd. 52 Week Low Streak in view.
- The cumulative move across the streak is down 0.88%, showing persistent weakness rather than one isolated decline.
- The stock’s P/E of 20.92 is below the industry median, while its P/B of 8.2 remains well above it.
- ROE of 44.5% and ROCE of 55.46% remain strong compared with the sector benchmark.
- Investors may want to watch whether the share price stays close to the yearly low or begins moving away from that zone.
About the Company
Sanofi India Ltd. is part of the Pharmaceuticals & Drugs industry in the Healthcare sector. The company has a market capitalisation of Rs 6,775.15 crore and is tracked on both NSE and BSE. Its reported financial metrics show a P/E of 20.92, P/B of 8.2, EPS of Rs 140.6 and book value of Rs 358.67. The stock’s current pattern keeps the Sanofi India Ltd. Share Price in the news, especially as it remains close to its 52-week low across multiple sessions.
For market readers, the important point is not only the current price level but the persistence of the move. The Sanofi India Ltd. 52 Week Low Streak highlights a repeated market pattern that should be read alongside profitability, valuation and sector comparison rather than in isolation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What does the Sanofi India Ltd. 52 Week Low Streak mean?
Ans. It means the stock has traded within 2% of its 52-week low for six consecutive sessions. The pattern signals sustained weakness near the yearly low, but it does not by itself explain the reason for the move.
How did Sanofi India Ltd. trade today?
Ans. It last traded at Rs 2,919.65, after opening at Rs 2,934 and touching a high of Rs 2,934 and a low of Rs 2,916.75. The stock remained close to the lower end of its day range.
How does Sanofi India Ltd. compare with its sector on valuation?
Ans. The stock’s P/E of 20.92 is below the industry median of 26.76, while its P/B of 8.2 is well above the industry median of 2.78. That makes the valuation picture mixed rather than simple.
What do the profitability ratios suggest?
Ans. ROE of 44.5% and ROCE of 55.46% are both strong versus the sector benchmark. These figures show healthy profitability even though the share price remains near its one-year low. ROE stands at 44.5%.
Should investors track the Sanofi India Ltd. 52 Week Low Streak further?
Ans. Yes, because repeated trading near a yearly low can remain a notable market signal. Investors may want to monitor whether the stock continues to stay in that zone or starts moving away from it.
Track Sanofi India Ltd. (SANOFI) Share Price on Univest
Use Sanofi India Ltd. (SANOFI) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.